“Bringing Next Generation Immunotherapy to Cancer”

In Clinical Development, Featured on App, Orphan Drug Congress by Freya Smale

John Maki of Vicus Therapeutics  joined us for World Orphan Drug Congress USA 2015 to present about ‘Bringing Next Generation Immunotherapy to Cancer’ .
Download the presentation now to learn more about:

  • Vicus’ next generation targets
  • First multi-pathway neuro-immune modulator for cancer
  • VT-122 pipeline in a product (today) 
  • VT-122 pipeline in a product (2018)
…and much more!
Get your copy here!
To find out more about  Vicus Therapeutics’ next generation immunotherapy , join us at  World Orphan Drug Congress USA 2016 April 20-22  in Washington, DC.